Niche biomedical focus SRI specializes in mathematical and computer models for biological and biomedical systems, presenting a strong fit for sales opportunities in pharma, biotech, toxicology, epidemiology, and biomedical engineering sectors seeking modeling, simulation, and data analysis capabilities.

Custom modeling services Given their emphasis on development and implementation of custom models, there is a sales opening for tailored software, consulting, and integration services that align with clients’ unique experimental designs, clinical workflows, and regulatory requirements.

Small team agility With an extremely small headcount, SRI may value scalable, cost-effective solutions, white-label offerings, or managed services that reduce overhead while delivering robust modeling outcomes.

Digital presence SRI maintains a basic web and analytics footprint (WordPress, Cloudflare, Google Analytics). Targeted outreach via digital marketing, case studies, and demonstration of model capabilities could yield high ROI with low acquisition costs.

Revenue tier Current revenue under $10M suggests growth potential through upsell of larger-scale modeling projects, ongoing maintenance, data services, and collaboration on grant-funded or contract research opportunities with mid-market to enterprise clients.